S&P 500   4,960.48 (-1.01%)
DOW   37,914.86 (+0.37%)
QQQ   414.27 (-2.16%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
S&P 500   4,960.48 (-1.01%)
DOW   37,914.86 (+0.37%)
QQQ   414.27 (-2.16%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
S&P 500   4,960.48 (-1.01%)
DOW   37,914.86 (+0.37%)
QQQ   414.27 (-2.16%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
S&P 500   4,960.48 (-1.01%)
DOW   37,914.86 (+0.37%)
QQQ   414.27 (-2.16%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
Free Trial
OTCMKTS:BXRXV

Baudax Bio (BXRXV) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free BXRXV Stock Alerts
Compare
Today's Range
N/A
50-Day Range
$4.51
▼
$4.51
52-Week Range
N/A
Volume
119,000 shs
Average Volume
53,220 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

BXRXV Stock News Headlines

March 20, 2024 | morningstar.com
Baudax Bio Inc Ordinary Shares BXRXQ
September 28, 2023 | stockhouse.com
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
August 23, 2023 | markets.businessinsider.com
Noble Financial Remains a Hold on Baudax Bio (BXRX)
June 30, 2023 | msn.com
What's Happening With Baudax Bio Shares Today
June 30, 2023 | msn.com
Baudax Bio Soars on Snapping Up Cell Therapy Developer TeraImmune
June 30, 2023 | finance.yahoo.com
Baudax Bio Acquires TeraImmune, Inc.
June 7, 2023 | benzinga.com
Baudax Bio Touts Additional Positive Data From Nerve Blocker In Surgery Patients
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
June 7, 2023 | technews.tmcnet.com
Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
June 6, 2023 | finance.yahoo.com
Baudax Bio Announces Date of Reconvened Annual Meeting
April 27, 2023 | finanznachrichten.de
Baudax Bio, Inc.: Baudax Bio Announces Pricing of $4 Million Public Offering
April 27, 2023 | msn.com
Baudax Bio stock dips on pricing $4M stock offering at $1.15/share
April 25, 2023 | finance.yahoo.com
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
March 27, 2023 | finance.yahoo.com
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
January 24, 2023 | finance.yahoo.com
Why Baudax Bio Shares Trading Higher Today
January 24, 2023 | finance.yahoo.com
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
January 14, 2023 | seekingalpha.com
BXRX Baudax Bio, Inc.
December 8, 2022 | finance.yahoo.com
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
December 6, 2022 | nz.finance.yahoo.com
Baudax Bio Announces Closing of $5 Million Public Offering
December 3, 2022 | finanznachrichten.de
Baudax Bio, Inc.: Baudax Bio Announces Pricing of $5 Million Public Offering
December 2, 2022 | nz.finance.yahoo.com
Baudax Bio Announces Pricing of $5 Million Public Offering
November 30, 2022 | yahoo.com
Baudax Bio Announces 1-for-40 Reverse Stock Split
November 8, 2022 | msn.com
Baudax Bio, Inc. (BXRX) Reports Q3 Loss, Lags Revenue Estimates
September 1, 2022 | benzinga.com
Baudax Bio Announces Closing of $6.2 Million Public Offering
September 1, 2022 | msn.com
How Is The Market Feeling About Baudax Bio?
August 30, 2022 | marketwatch.com
Baudax Bio Shares Tumble Premarket After Public Offering >BXRX
See More Headlines
Receive BXRXV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baudax Bio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:BXRXV
CUSIP
N/A
CIK
N/A
Web
www.baudaxbio.com
Phone
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

BXRXV Stock Analysis - Frequently Asked Questions

How do I buy shares of Baudax Bio?

Shares of BXRXV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BXRXV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press